Mariela von Uckermann
Biomedical Analyst at Biology Education Centre
- E-mail:
- mariela.von_uckermann@ibg.uu.se
- Visiting address:
- EBC, Norbyvägen 14 / BMC A8:1
- Postal address:
- Norbyvägen 14, 752 36 UPPSALA/Box 592
751 24 UPPSALA
Download contact information for Mariela von Uckermann at Biology Education Centre
Research Engineer at Department of Immunology, Genetics and Pathology; Research programme: Cancer Immunotherapy; Research group Angelica Loskog
- E-mail:
- mariela.mejia_cordova@igp.uu.se
- Visiting address:
- Dag Hammarskjölds väg 20
751 85 Uppsala - Postal address:
- Rudbecklaboratoriet
751 85 UPPSALA
- CV:
- Download CV

Publications
Selection of publications
-
Part of Journal of Cellular and Molecular Medicine, 2024
- DOI for CD40 stimulation via CD40 ligand enhances adenovirus-mediated tumour immunogenicity including 'find-me', 'eat-me', and 'kill-me' signalling
- Download full text (pdf) of CD40 stimulation via CD40 ligand enhances adenovirus-mediated tumour immunogenicity including 'find-me', 'eat-me', and 'kill-me' signalling
-
Assessing the Effectiveness of Interleukin-2 Therapy in Experimental Type 1 Diabetes
Part of Endocrine, p. 626-637, 2024
- DOI for Assessing the Effectiveness of Interleukin-2 Therapy in Experimental Type 1 Diabetes
- Download full text (pdf) of Assessing the Effectiveness of Interleukin-2 Therapy in Experimental Type 1 Diabetes
-
Part of International Journal of Molecular Sciences, 2021
- DOI for Interleukin-35 Prevents Development of Autoimmune Diabetes Possibly by Maintaining the Phenotype of Regulatory B Cells
- Download full text (pdf) of Interleukin-35 Prevents Development of Autoimmune Diabetes Possibly by Maintaining the Phenotype of Regulatory B Cells
-
Part of FASEB BioAdvances, p. 538-549, 2019
- DOI for Kinetics of immune cell responses in the multiple low dose streptozotocin mouse model of type 1 diabetes
- Download full text (pdf) of Kinetics of immune cell responses in the multiple low dose streptozotocin mouse model of type 1 diabetes
-
Part of Oncotarget, p. 18720-18733, 2018
- DOI for Pro-tumoral immune cell alterations in wild type and Shb-deficient mice in response to 4T1 breast carcinomas
- Download full text (pdf) of Pro-tumoral immune cell alterations in wild type and Shb-deficient mice in response to 4T1 breast carcinomas
-
Kinetics of the innate immune cell responses in experimental Type 1 Diabetes
Part of Scandinavian Journal of Immunology, p. 303-304, 2017
-
Role of regulatory B cells in clinical and experimental type 1 diabetes
Part of Scandinavian Journal of Immunology, p. 349-349, 2017
Recent publications
-
Part of Journal of Cellular and Molecular Medicine, 2024
- DOI for CD40 stimulation via CD40 ligand enhances adenovirus-mediated tumour immunogenicity including 'find-me', 'eat-me', and 'kill-me' signalling
- Download full text (pdf) of CD40 stimulation via CD40 ligand enhances adenovirus-mediated tumour immunogenicity including 'find-me', 'eat-me', and 'kill-me' signalling
-
Assessing the Effectiveness of Interleukin-2 Therapy in Experimental Type 1 Diabetes
Part of Endocrine, p. 626-637, 2024
- DOI for Assessing the Effectiveness of Interleukin-2 Therapy in Experimental Type 1 Diabetes
- Download full text (pdf) of Assessing the Effectiveness of Interleukin-2 Therapy in Experimental Type 1 Diabetes
-
Part of International Journal of Molecular Sciences, 2021
- DOI for Interleukin-35 Prevents Development of Autoimmune Diabetes Possibly by Maintaining the Phenotype of Regulatory B Cells
- Download full text (pdf) of Interleukin-35 Prevents Development of Autoimmune Diabetes Possibly by Maintaining the Phenotype of Regulatory B Cells
-
Part of Scientific Reports, 2019
- DOI for The Cdh5-CreERT2 transgene causes conditional Shb gene deletion in hematopoietic cells with consequences for immune cell responses to tumors
- Download full text 1 (pdf) of The Cdh5-CreERT2 transgene causes conditional Shb gene deletion in hematopoietic cells with consequences for immune cell responses to tumors
- Download full text 2 (pdf) of The Cdh5-CreERT2 transgene causes conditional Shb gene deletion in hematopoietic cells with consequences for immune cell responses to tumors
-
Part of FASEB BioAdvances, p. 538-549, 2019
- DOI for Kinetics of immune cell responses in the multiple low dose streptozotocin mouse model of type 1 diabetes
- Download full text (pdf) of Kinetics of immune cell responses in the multiple low dose streptozotocin mouse model of type 1 diabetes
All publications
Articles in journal
-
Part of Journal of Cellular and Molecular Medicine, 2024
- DOI for CD40 stimulation via CD40 ligand enhances adenovirus-mediated tumour immunogenicity including 'find-me', 'eat-me', and 'kill-me' signalling
- Download full text (pdf) of CD40 stimulation via CD40 ligand enhances adenovirus-mediated tumour immunogenicity including 'find-me', 'eat-me', and 'kill-me' signalling
-
Assessing the Effectiveness of Interleukin-2 Therapy in Experimental Type 1 Diabetes
Part of Endocrine, p. 626-637, 2024
- DOI for Assessing the Effectiveness of Interleukin-2 Therapy in Experimental Type 1 Diabetes
- Download full text (pdf) of Assessing the Effectiveness of Interleukin-2 Therapy in Experimental Type 1 Diabetes
-
Part of International Journal of Molecular Sciences, 2021
- DOI for Interleukin-35 Prevents Development of Autoimmune Diabetes Possibly by Maintaining the Phenotype of Regulatory B Cells
- Download full text (pdf) of Interleukin-35 Prevents Development of Autoimmune Diabetes Possibly by Maintaining the Phenotype of Regulatory B Cells
-
Part of Scientific Reports, 2019
- DOI for The Cdh5-CreERT2 transgene causes conditional Shb gene deletion in hematopoietic cells with consequences for immune cell responses to tumors
- Download full text 1 (pdf) of The Cdh5-CreERT2 transgene causes conditional Shb gene deletion in hematopoietic cells with consequences for immune cell responses to tumors
- Download full text 2 (pdf) of The Cdh5-CreERT2 transgene causes conditional Shb gene deletion in hematopoietic cells with consequences for immune cell responses to tumors
-
Part of FASEB BioAdvances, p. 538-549, 2019
- DOI for Kinetics of immune cell responses in the multiple low dose streptozotocin mouse model of type 1 diabetes
- Download full text (pdf) of Kinetics of immune cell responses in the multiple low dose streptozotocin mouse model of type 1 diabetes
-
Part of Oncotarget, p. 18720-18733, 2018
- DOI for Pro-tumoral immune cell alterations in wild type and Shb-deficient mice in response to 4T1 breast carcinomas
- Download full text (pdf) of Pro-tumoral immune cell alterations in wild type and Shb-deficient mice in response to 4T1 breast carcinomas
-
Kinetics of the innate immune cell responses in experimental Type 1 Diabetes
Part of Scandinavian Journal of Immunology, p. 303-304, 2017
-
Role of regulatory B cells in clinical and experimental type 1 diabetes
Part of Scandinavian Journal of Immunology, p. 349-349, 2017